부산대학교 도서관

Benezit Dictionary of Artists, 2011

G. Maggioni; G. Todisco; E. Sauta; L. Lanino; S. Ball; Jp Bewersdorf; T Kewan; Nh Al Ali; P. Fenaux; U Platzbecker; V. Santini; Z Xie; AM. Brunner; At Kuykendall; JM. Bennett; R. Buckstein; R. Bejar; He Carraway; Ae Dezern; Ea Griffiths; S. Halene; Rp Hasserjian; Af List; S. Loghavi; O Odenike; E. Padron; MM. Patnaik; Gj Roboz; Maximilian Stahl; Ma Sekeres; Dp Steensma; Mr Savona; J Taylor; Ml Xu; Da Sallman; Sd Nimer; Cs Hourigan; Ah Wei; A. Campagna; M. Ubezio; E. Riva; D. Ventura; N. Pinocchio; M. Zampini; A. Buizza; A. Russo; F. Pesce; G. Asti; M. Delleani; E. Travaglino; Ca Tentori; I. Ferrari; A. Crespi; G. Figini; M. Di Matteo; M. Brindisi; L. Crisafulli; F. Ficara; G. Castellani; UM. Borate; F. Efficace; Sd Gore; Tk Kim; Aa Van De Loosdrecht; N. Daver; M. Rozman; A. Orfao; Sa Wang; K Foucar; M. Iastrebner; P. Scheinberg; Y Miyazaki; M. Mittelmann; T Cluzeau; L. Ades; U Germing; S. Kordasti; T Haferlach; AM. Zeidan; Rs Komrokji; Mg Della Porta.

Haematologica, Vol 110, Iss s1 (2025)

Zeidan, AM; Platzbecker, U; Bewersdorf, JP; Stahl, M; Ades, L; Borate, U; Bowen, D; Buckstein, R; Brunner, A; Carraway, HE

BLOOD. 141(17):2047-2061

Patel M; Department of Internal Medicine, Cleveland Clinic, Cleveland, OH.; Zabor EC; Department of Quantitative Health Sciences, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.; Mohamed A; Department of Internal Medicine, Cleveland Clinic, Cleveland, OH.; Zureigat H; Department of Internal Medicine, Cleveland Clinic, Cleveland, OH.; Chen MJ; Department of Pathology and Laboratory Medicine, Cleveland Clinic Diagnostics Institute, Cleveland, OH.; Nakitandwe J; Department of Pathology and Laboratory Medicine, Cleveland Clinic Diagnostics Institute, Cleveland, OH.; Tu ZJ; Department of Pathology and Laboratory Medicine, Cleveland Clinic Diagnostics Institute, Cleveland, OH.; Jain AG; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.; Molina JC; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.; Balderman S; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.; Singh A; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.; Gerds AT; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.; Mukherjee S; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.; Carraway HE; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.; Advani AS; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.; Mustafa Ali MK; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

Albliwi M; Department of Internal Medicine, Cleveland Clinic, Cleveland, OH.; Zabor EC; Department of Quantitative Health Sciences, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.; Hanna J; Department of Internal Medicine, Cleveland Clinic, Cleveland, OH.; El-Asmar J; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.; Nurse DP; Department of Internal Medicine, Cleveland Clinic, Cleveland, OH.; Bawwab A; Department of Internal Medicine, Cleveland Clinic, Cleveland, OH.; Abuamsha H; Department of Internal Medicine, Cleveland Clinic, Cleveland, OH.; Abu-Farsakh Y; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.; Rauf A; Department of Internal Medicine, Cleveland Clinic, Cleveland, OH.; Batah H; Department of Internal Medicine, Cleveland Clinic, Cleveland, OH.; Mohamed A; Department of Internal Medicine, Cleveland Clinic, Cleveland, OH.; Alchirazi MA; Department of Internal Medicine, Cleveland Clinic, Cleveland, OH.; Jain AG; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.; Molina JC; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.; Balderman S; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.; Singh A; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.; Gerds AT; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.; Mukherjee S; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.; Sobecks RM; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Blood and Marrow Transplant Program, Cleveland, OH.; Hamilton B; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Blood and Marrow Transplant Program, Cleveland, OH.; Advani AS; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.; Carraway HE; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.; Mustafa Ali MK; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH. Electronic address: Mustafm8@ccf.org.

Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

Yu K; Dillon LW; Tettero JM; Gui G; Al-Ali RW; Grunwald MR; Krakow EF; Griffiths EA; Gomez-Arteaga A; Vedula RS; Solh M; Salhotra A; Bejanyan N; Muffly L; Jimenez-Jimenez AM; Drazer MW; Chen YB; Logan A; Jayani-Kosarzycki RV; Balderman SR; Blachly JS; Shaffer BC; Druhan LJ; Yeung CC; Kennedy VE; Fathi AT; Carraway HE; Gurbuxani S; Tjota MY; Sahoo F; Smith M; Barfield D; Guo J; Han J; Hu J; Jo H; Kudlingar V; Li W; Qiu Y; Sathyan P; Truong S; Catreux S; Ng S; Luong K; Zhu Y; Bahr R; Diemer J; Ferrone CK; Getker AJ; Bjerke J; Bo-Subait S; Devine SM; Dietel B; Giammarino G; Chihak EH; Kou J; Kolb E; Vitali DO; Spellman SR; Tesch BK; Vogel J; Waldvogel S; Weatherspoon S; Auletta JJ; Hourigan CS

Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not MEDLINE

Shwetha Srinivasan; Raju Regmi; Xingcheng Lin; Courtney A. Dreyer; Xuyan Chen; Steven D. Quinn; Wei He; Matthew A. Coleman; Kermit L. Carraway; Bin Zhang; Gabriela S. Schlau-Cohen

Nature Communications, Vol 13, Iss 1, Pp 1-11 (2022)

Carraway HE; Cleveland Clinic, Leukemia Program, Taussig Cancer Institute, Cleveland, OH.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 100890099 Publication Model: Print Cited Medium: Internet ISSN: 1520-4383 (Electronic) Linking ISSN: 15204383 NLM ISO Abbreviation: Hematology Am Soc Hematol Educ Program Subsets: MEDLINE

The Guardian (London, England). September 29, 2012, p8

Robinette ML; Brigham and Women's Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, Massachusetts.; Carraway HE; Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.

Publisher: Wiley Country of Publication: United States NLM ID: 101623795 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-5205 (Electronic) Linking ISSN: 23265191 NLM ISO Abbreviation: Arthritis Rheumatol Subsets: In Process; MEDLINE

Ball S; Vanderbilt Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.; Jain AG; Leukemia Program, Taussig Cancer Institute, Cleveland, Ohio, USA.; Al Ali N; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.; Aguirre LE; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Bewersdorf JP; Yale Cancer Center, New Haven, Connecticut, USA.; Kent A; University of Colorado Cancer Center, Aurora, Colorado, USA.; Rose A; Leukemia Program, Taussig Cancer Institute, Cleveland, Ohio, USA.; Hayden A; University of Colorado Cancer Center, Aurora, Colorado, USA.; Siddon A; Yale Cancer Center, New Haven, Connecticut, USA.; Lykon J; Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, USA.; Madarang E; Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, USA.; Swoboda DM; Tampa General Hospital Cancer Institute, Tampa, Florida, USA.; Padron E; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.; Sweet K; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.; Sallman DA; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.; Lancet J; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.; Carraway HE; Leukemia Program, Taussig Cancer Institute, Cleveland, Ohio, USA.; Watts J; Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, USA.; Zeidan A; Yale Cancer Center, New Haven, Connecticut, USA.; Pollyea DA; University of Colorado Cancer Center, Aurora, Colorado, USA.; Komrokji RS; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.

Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: In Process; MEDLINE

Mohamed A; Department of Internal Medicine, Cleveland Clinic, Cleveland, OH.; Zabor EC; Department of Quantitative Health Sciences, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.; Patel M; Department of Internal Medicine, Cleveland Clinic, Cleveland, OH.; Zureigat H; Department of Internal Medicine, Cleveland Clinic, Cleveland, OH.; Albliwi M; Department of Internal Medicine, Cleveland Clinic, Cleveland, OH.; Chen MJ; Department of Pathology and Laboratory Medicine, Cleveland Clinic Diagnostics Institute, Cleveland, OH.; Nakitandwe J; Department of Pathology and Laboratory Medicine, Cleveland Clinic Diagnostics Institute, Cleveland, OH.; Bosler DS; Department of Pathology and Laboratory Medicine, Cleveland Clinic Diagnostics Institute, Cleveland, OH.; Kurish H; Department of Pharmacy, Cleveland Clinic, Cleveland, OH.; Jain AG; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.; Molina JC; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.; Balderman S; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.; Singh A; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.; Gerds AT; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.; Mukherjee S; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.; Carraway HE; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.; Advani AS; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.; Mustafa Ali MK; Department of Pharmacy, Cleveland Clinic, Cleveland, OH. Electronic address: Mustafm8@ccf.org.

Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

Hanna J; Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA.; Zabor EC; Department of Quantitative Health Sciences, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA.; Albliwi M; Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA.; El-Asmar J; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA.; Nurse DP; Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA.; Bawwab A; Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA.; Abuamsha H; Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA.; Abu-Farsakh Y; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA.; Batah H; Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA.; Rauf A; Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA.; Nakitandwe J; Department of Pathology and Laboratory Medicine, Cleveland Clinic Diagnostics Institute, Cleveland, Ohio, USA.; Bosler DS; Department of Pathology and Laboratory Medicine, Cleveland Clinic Diagnostics Institute, Cleveland, Ohio, USA.; Jain AG; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA.; Molina JC; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA.; Balderman S; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA.; Singh A; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA.; Gerds AT; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA.; Mukherjee S; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA.; Sobecks RM; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA.; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Blood and Marrow Transplant Program, Cleveland, Ohio, USA.; Advani AS; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA.; Carraway HE; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA.; Astbury C; Department of Pathology and Laboratory Medicine, Cleveland Clinic Diagnostics Institute, Cleveland, Ohio, USA.; Mustafa Ali MK; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA.

Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

Efficace F; Italian Group for Adult Hematologic Diseases (GIMEMA), Health Outcomes Research Unit GIMEMA Data Center Rome Italy.; Buckstein R; Department of Medical Oncology/Hematology Sunnybrook Health Sciences Centre Toronto Ontario Canada.; Abel GA; Divisions of Population Sciences and Hematologic Malignancies Dana-Farber Cancer Institute Boston Massachusetts USA.; Giesinger JM; University Hospital of Psychiatry II Medical University of Innsbruck Innsbruck Austria.; Fenaux P; Hôpital Saint Louis Assistance Publique Hôpitaux de Paris and Paris Cité University Paris France.; Bewersdorf JP; Leukemia Service, Department of Medicine Memorial Sloan Kettering Cancer Center New York New York USA.; Brunner AM; Leukemia Program, Harvard Medical School Massachusetts General Hospital Cancer Center Boston Massachusetts USA.; Bejar R; Division of Hematology and Oncology, Moores Cancer Center UC San Diego La Jolla California USA.; Borate U; Ohio State University Comprehensive Cancer Center/James Cancer Hospital Ohio State University Columbus Ohio USA.; DeZern AE; Sidney Kimmel Comprehensive Cancer Center Johns Hopkins Hospital Baltimore Maryland USA.; Greenberg P; Department of Medicine, Division of Hematology, Cancer Institute Stanford University School of Medicine Stanford California USA.; Roboz GJ; Weill Cornell Medical College and New York Presbyterian Hospital New York New York USA.; Savona MR; Department of Medicine, Division of Hematology/Oncology Vanderbilt University Medical Center Nashville Tennessee USA.; Sparano F; Italian Group for Adult Hematologic Diseases (GIMEMA), Health Outcomes Research Unit GIMEMA Data Center Rome Italy.; Boultwood J; Blood Cancer UK Molecular Haematology Unit, Radcliffe Department of Medicine Nuffield Division of Clinical Laboratory Sciences University of Oxford Oxford UK.; Komrokji R; Department of Malignant Hematology H. Lee Moffitt Cancer Center Tampa Florida USA.; Sallman DA; Department of Malignant Hematology H. Lee Moffitt Cancer Center Tampa Florida USA.; Xie Z; Department of Malignant Hematology H. Lee Moffitt Cancer Center Tampa Florida USA.; Sanz G; Health Research Institute La Fe, Valencia, Spain Hospital Universitario y Politécnico La Fe Valencia Spain.; Carraway HE; Leukemia Program, Hematology and Medical Oncology Taussig Cancer Institute, Cleveland Clinic Cleveland Ohio USA.; Taylor J; Sylvester Comprehensive Cancer Center University of Miami Miller School of Medicine Miami Florida USA.; Nimer SD; Sylvester Comprehensive Cancer Center University of Miami Miller School of Medicine Miami Florida USA.; Della Porta MG; Department of Biomedical Sciences IRCCS Humanitas Clinical and Research Center & Humanitas University Milan Italy.; Santini V; Myelodysplastic Syndromes Unit, Department of Experimental and Clinical Medicine, Hematology, Azienda Ospedaliero Universitaria Careggi University of Florence Florence Italy.; Stahl M; Department of Medical Oncology Dana-Farber Cancer Institute and Harvard Medical School Boston Massachusetts USA.; Platzbecker U; Department of Hematology and Cellular Therapy University Hospital Leipzig Leipzig Germany.; Sekeres MA; Sylvester Comprehensive Cancer Center University of Miami Miller School of Medicine Miami Florida USA.; Zeidan AM; Section of Hematology, Department of Internal Medicine Yale University School of Medicine and Yale Cancer Center New Haven Connecticut USA.

Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE

Molina JC; Leukemia Program, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, 44195, USA. molinaj3@ccf.org.; Carraway HE; Leukemia Program, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, 44195, USA.

Publisher: Current Science, Inc Country of Publication: United States NLM ID: 100900946 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-6277 (Electronic) Linking ISSN: 15346277 NLM ISO Abbreviation: Curr Treat Options Oncol Subsets: MEDLINE

Gordon J; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.; Bravo-Perez C; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.; Department of Hematology and Medical Oncology, Hospital Universitario Morales Meseguer, University of Murcia, IMIB-Pascual Parrilla, CIBERER - Instituto de Salud Carlos III, Murcia, Spain.; Guarnera L; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.; Unlu S; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.; Kawashima N; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.; Ahmed A; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.; Haddad C; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.; Kubota Y; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.; Nautiyal I; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.; Ullah F; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.; Dima D; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.; Williams ND; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.; Kewan T; Department of Hematology and Medical Oncology, Yale University, New Haven, CT, USA.; Bahaj W; Division of Medical Oncology & Hematology, School of Medicine University of Louisville, Louisville, KY, USA.; Carraway HE; Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.; Yang CY; Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, USA.; Gurnari C; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.; Visconte V; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.; Maciejewski JP; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA. maciejj@ccf.org.

Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

DeZern AE; Johns Hopkins University, Hematologic Malignancies, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD.; Thepot S; Centre Hospitalier Universitaire, Hematology, Angers, France.; de Botton S; Institut Gustave Roussy, Department of Hematology, Villejuif, France.; Patriarca A; Hematology Unit, AOU Maggiore della Carità and University of Eastern Piedmont, Novara, Italy.; Deeren D; AZ Delta, Department of Hematology, Roeselare, Belgium.; Torregrossa-Diaz JM; Centre Hospitalier Universitaire de Poitiers, University Hospital of Poitiers, Department of Hematology, Poitiers, France.; Marconi G; Romagnolo Institute to Study Tumors 'Dino Amadori,' Department of Hematology, Meldola, Italy.; Bernal T; Hospital Universitario Central de Asturias, Department of Hematology, Oviedo, Spain.; Bergua Burgues J; Hospital San Pedro de Alcántara, Department of Hematology, Caceres, Spain.; Xicoy B; Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Josep Carreras Deparment of Leukemia Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.; Jonášová A; Medical Department Hematology, Charles University General Hospital, Prague, Czech Republic.; Zeidan AM; Yale University and Yale Cancer Center, Division of Hematologic Maignancies, New Haven, CT.; Dimicoli-Salazar S; Hôpital Haut-Lévêque, Centre Hospitalier Universitaire de Bordeaux, Hematology, Bordeaux, France.; Simand C; Institut de Cancérologie de Strasbourg Europe, Hematology, Strasbourg, France.; Valcarcel D; Hospital Universitario Vall d'Hebron, Department of Hematology, Barcelona, Spain.; Diez Campelo M; Hospital Universitario de Salamanca, Institute of Biomedical Research of Salamanca, Salamanca, Spain.; Chai-Ho W; Division of Hematology and Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA.; Saini L; Division of Hematology, Department of Medicine, London Health Sciences Centre, London, ON, Canada.; Garnier A; Hematology Clinic, Nantes University Hospital, Nantes, France.; Geissler K; Hospital Hietzing, Vienna, Austria.; Ofran Y; Department of Hematology, Shaarei Zedek Medical Center, Jerusalem, Israel.; Nagy Z; Department of Internal Medicine and Hematology, Semmelweis University, Budapest, Hungary.; Krishnamurthy P; Department of Haematological Medicine, King's College Hospital, London, United Kingdom.; Lübbert M; University of Freiburg Medical Center, Freiburg, Germany.; Basak G; Medical University of Warsaw, Warsaw, Poland.; Carraway HE; Leukemia Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.; Sallman DA; Moffitt Cancer Center and Research Institute, Department of Malignant Hematology, Tampa, FL.; Borate U; Leukemia and Hematologic Malignancies Program, The Ohio State University, Columbus, OH.; Santini V; MDS Unit, Department of Medical Sciences and Public Health, AOU Careggi, University of Florence, Firenze, Italy.; Campbell V; Lothian Health Board Western General Hospital in National Health Service Lothian, Edinburgh, Scotland.; Fenaux P; Département d'Hématologie et Immunologie, Assistance Publique-Hôpitaux de Paris Nord Service d'Hématologie Seniors Hôpital St Louis/Université de Paris, Paris, France.; Braun T; Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris Service Hématologie, Paris, France.; Lanza F; Ospedale Santa Maria delle Croci, Hematology, Ravenna, Italy.; Zaucha JM; Department of Haematology and Transplantology, Medical University of Gdańsk University Clinical Center, Gdańsk, Poland.; Roth DA; Syros Pharmaceuticals, Inc, Cambridge, MA.; Paul S; Syros Pharmaceuticals, Inc, Cambridge, MA.; Roy P; Syros Pharmaceuticals, Inc, Cambridge, MA.; Kelly MJ; Syros Pharmaceuticals, Inc, Cambridge, MA.; Volkert A; Syros Pharmaceuticals, Inc, Cambridge, MA.; Chisholm J; Syros Pharmaceuticals, Inc, Cambridge, MA.; Malak TA; Syros Pharmaceuticals, Inc, Cambridge, MA.; Klimek VM; Syros Pharmaceuticals, Inc, Cambridge, MA.; Cluzeau T; Centre Hospitalier Universitaire de Nice, Nice, France.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Mukherjee S; Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.; Population Cancer Analytics Shared Resource, Case Comprehensive Cancer Center, Cleveland, OH.; Dong W; Population Cancer Analytics Shared Resource, Case Comprehensive Cancer Center, Cleveland, OH.; Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH.; Gerds AT; Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.; Carraway HE; Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.; Singh A; Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.; Advani AS; Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.; Mustafa Ali MK; Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.; Molina JC; Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.; Balderman S; Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.; Jain A; Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.; Caimi P; Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.; Anwer F; Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.; Sekeres MA; Division of Hematology, Sylvester Comprehensive Cancer Center, University of Florida, Miami, FL.; Koroukian SM; Population Cancer Analytics Shared Resource, Case Comprehensive Cancer Center, Cleveland, OH.; Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH.

Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 9918841988906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2950-3280 (Electronic) Linking ISSN: 29503280 NLM ISO Abbreviation: Blood Neoplasia Subsets: PubMed not MEDLINE

Carraway HE; Division of Hematologic Oncology and Blood Disorders, Leukemia Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH; Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH. Electronic address: carrawh@ccf.org.; Brunner AM; Leukemia Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Lai CE; Leukemia Clinical Research Unit, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA.; Luskin MR; Division of Leukemia, Dana Farber Cancer Institute, Boston, MA.; Park J; Cellular Therapy Service, Deparment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Perl AE; Leukemia Clinical Research Unit, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA.; Stein EM; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Wang ES; Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY.; Zeidan AM; Department of Internal Medicine, Yale University, New Haven, CT.; Zeidner JF; Division of Hematology, Department of Medicine, University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC.; Komrokji R; Malignant Hematology Department, Moffitt Cancer Center, Tampa, FL.

Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

Aribi A; City of Hope, Duarte, CA.; Mannis GN; Stanford Cancer Institute, Stanford University, Stanford, CA.; Madanat YF; University of Texas Southwestern, Dallas, TX.; Jonas BA; University of California Davis Comprehensive Cancer Center, Sacramento, CA.; Dunavin N; University of California San Francisco, San Francisco, CA.; Roboz GJ; Weill Cornell Medicine and The New York Hospital, New York, NY.; Jeyakumar D; University of California Irvine Health, Orange, CA.; Garcia-Manero G; The University of Texas MD Anderson Cancer Center, Houston, TX.; Liu H; University of Chicago Medicine, Chicago, IL.; Carraway HE; Leukemia Program, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH.; Saultz JN; Oregon Health & Science University, Portland, OR.; Blum W; Winship Cancer Institute of Emory University, Atlanta, GA.; Schiller G; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA.; Huang T; Immune-Onc Therapeutics, Inc, Palo Alto, CA.; Woodard P; Immune-Onc Therapeutics, Inc, Palo Alto, CA.; Klencke B; Immune-Onc Therapeutics, Inc, Palo Alto, CA.; Liao XC; Immune-Onc Therapeutics, Inc, Palo Alto, CA.; Xiang H; Immune-Onc Therapeutics, Inc, Palo Alto, CA.; Pollyea DA; University of Colorado, Aurora, CO.; DiNardo CD; The University of Texas MD Anderson Cancer Center, Houston, TX.

Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 9918841988906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2950-3280 (Electronic) Linking ISSN: 29503280 NLM ISO Abbreviation: Blood Neoplasia Subsets: In Process